πŸ‡ΊπŸ‡Έ FDA
Patent

US 8034822

Glucokinase activators

granted A61PA61P15/08A61P3/00

Quick answer

US patent 8034822 (Glucokinase activators) held by Takeda San Diego, Inc. expires Mon Oct 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda San Diego, Inc.
Grant date
Tue Oct 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61P, A61P15/08, A61P3/00, A61P3/04, A61P3/06